Prospective Clinical Study on the Clinical Efficacy and Prognostic Outcome of ICS/LABA Combined With Liqin Zhike Formula in the Treatment of Cough Variant Asthma

NCT07272278 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

236

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: ICS+LABA
DRUG: Chinese Medicine Formula

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University